Literature DB >> 22998064

Galectin 3 complements BNP in risk stratification in acute heart failure.

Gregory J Fermann1, Christopher J Lindsell, Alan B Storrow, Kimberly Hart, Matthew Sperling, Susan Roll, Neal L Weintraub, Karen F Miller, David J Maron, Allen J Naftilan, John A McPherson, Douglas B Sawyer, Robert Christenson, Sean P Collins.   

Abstract

BACKGROUND: Galectin 3 (G3) is a mediator of fibrosis and remodeling in heart failure.
METHODS: Patients diagnosed with and treated for Acute Heart Failure Syndromes were prospectively enrolled in the Decision Making in Acute Decompensated Heart Failure multicenter trial.
RESULTS: Patients with a higher G3 had a history of renal disease, a lower heart rate and acute kidney injury. They also tended to have a history of HF and 30-day adverse events compared with B-type natriuretic peptide.
CONCLUSION: In Acute Heart Failure Syndromes, G3 levels do not provide prognostic value, but when used complementary to B-type natriuretic peptide, G3 is associated with renal dysfunction and may predict 30-day events.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22998064      PMCID: PMC3678263          DOI: 10.3109/1354750X.2012.719037

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  25 in total

1.  Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.

Authors:  Roland R van Kimmenade; James L Januzzi; Patrick T Ellinor; Umesh C Sharma; Jaap A Bakker; Adrian F Low; Abelardo Martinez; Harry J Crijns; Calum A MacRae; Paul P Menheere; Yigal M Pinto
Journal:  J Am Coll Cardiol       Date:  2006-08-28       Impact factor: 24.094

2.  Gray zone BNP levels in heart failure patients in the emergency department: results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study.

Authors:  Cynthia K Brenden; Judd E Hollander; David Guss; Peter A McCullough; Richard Nowak; Gary Green; Mitchell Saltzberg; Stefanie R Ellison; Meenakshi Awasthi Bhalla; Vikas Bhalla; Paul Clopton; Robert Jesse; Alan S Maisel
Journal:  Am Heart J       Date:  2006-05       Impact factor: 4.749

3.  The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

Authors:  James L Januzzi; Carlos A Camargo; Saif Anwaruddin; Aaron L Baggish; Annabel A Chen; Daniel G Krauser; Roderick Tung; Renee Cameron; J Tobias Nagurney; Claudia U Chae; Donald M Lloyd-Jones; David F Brown; Stacy Foran-Melanson; Patrick M Sluss; Elizabeth Lee-Lewandrowski; Kent B Lewandrowski
Journal:  Am J Cardiol       Date:  2005-04-15       Impact factor: 2.778

4.  Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction.

Authors:  Umesh C Sharma; Saraswati Pokharel; Thomas J van Brakel; Jop H van Berlo; Jack P M Cleutjens; Blanche Schroen; Sabine André; Harry J G M Crijns; Hans-J Gabius; Jos Maessen; Yigal M Pinto
Journal:  Circulation       Date:  2004-11-01       Impact factor: 29.690

5.  Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis.

Authors:  Neil C Henderson; Alison C Mackinnon; Sarah L Farnworth; Tiina Kipari; Christopher Haslett; John P Iredale; Fu-Tong Liu; Jeremy Hughes; Tariq Sethi
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

6.  B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study.

Authors:  Peter A McCullough; Richard M Nowak; James McCord; Judd E Hollander; Howard C Herrmann; Philippe G Steg; Philippe Duc; Arne Westheim; Torbjørn Omland; Cathrine Wold Knudsen; Alan B Storrow; William T Abraham; Sumant Lamba; Alan H B Wu; Alberto Perez; Paul Clopton; Padma Krishnaswamy; Radmila Kazanegra; Alan S Maisel
Journal:  Circulation       Date:  2002-07-23       Impact factor: 29.690

Review 7.  A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure.

Authors:  Jenny A Doust; Paul P Glasziou; Eva Pietrzak; Annette J Dobson
Journal:  Arch Intern Med       Date:  2004-10-11

8.  Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE.

Authors:  Gregg C Fonarow; William F Peacock; Tamara B Horwich; Christopher O Phillips; Michael M Givertz; Margarita Lopatin; Janet Wynne
Journal:  Am J Cardiol       Date:  2007-12-03       Impact factor: 2.778

9.  Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure.

Authors:  Jochem Hogenhuis; Adriaan A Voors; Tiny Jaarsma; Arno W Hoes; Hans L Hillege; Johannes A Kragten; Dirk J van Veldhuisen
Journal:  Eur J Heart Fail       Date:  2007-05-25       Impact factor: 15.534

10.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Wayne Rosamond; Katherine Flegal; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan M Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Bret Kissela; Steven Kittner; Donald Lloyd-Jones; Mary McDermott; James Meigs; Claudia Moy; Graham Nichol; Christopher O'Donnell; Veronique Roger; Paul Sorlie; Julia Steinberger; Thomas Thom; Matt Wilson; Yuling Hong
Journal:  Circulation       Date:  2007-12-17       Impact factor: 29.690

View more
  12 in total

Review 1.  Clinical use of novel biomarkers in heart failure: towards personalized medicine.

Authors:  Daniela Schmitter; Gadi Cotter; Adriaan A Voors
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

Review 2.  Review of the prognostic value of galectin-3 in heart failure focusing on clinical utility of repeated testing.

Authors:  Francisco Javier Carrasco-Sánchez; María Inmaculada Páez-Rubio
Journal:  Mol Diagn Ther       Date:  2014-12       Impact factor: 4.074

3.  Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure.

Authors:  R I Lala; D Lungeanu; D Darabantiu; L Pilat; M Puschita
Journal:  Herz       Date:  2017-02-24       Impact factor: 1.443

Review 4.  Stem cell therapy for chronic heart failure: an updated appraisal.

Authors:  Simon Maltais; Steven J Joggerst; Antonis Hatzopoulos; Thomas G DiSalvo; David Zhao; Hak-Joon Sung; Xintong Wang; John G Byrne; Allen J Naftilan
Journal:  Expert Opin Biol Ther       Date:  2013-01-06       Impact factor: 4.388

Review 5.  Determinants of survival following hospitalization for acute heart failure.

Authors:  Marwan F Jumean; Michael S Kiernan
Journal:  Curr Heart Fail Rep       Date:  2014-06

Review 6.  The emerging role of Galectin-3 and ST2 in heart failure: practical considerations and pitfalls using novel biomarkers.

Authors:  George Karayannis; Filippos Triposkiadis; John Skoularigis; Panagiotis Georgoulias; Javed Butler; Gregory Giamouzis
Journal:  Curr Heart Fail Rep       Date:  2013-12

7.  Assessment of Galectin-3 Polymorphism in Subjects with Chronic Chagas Disease.

Authors:  Gabriela da Silva Cruz; Ana Luiza Dias Angelo; Ticiana Ferreira Larocca; Carolina Thé Macedo; Márcia Noya-Rabelo; Luís Claudio Lemos Correia; Jorge Andion Torreão; Bruno Solano de Freitas Souza; Ricardo Ribeiro Dos Santos; Milena Botelho Pereira Soares
Journal:  Arq Bras Cardiol       Date:  2015-08-25       Impact factor: 2.000

Review 8.  Long-term sequelae from acute kidney injury: potential mechanisms for the observed poor renal outcomes.

Authors:  Matt Varrier; Lui G Forni; Marlies Ostermann
Journal:  Crit Care       Date:  2015-03-16       Impact factor: 9.097

Review 9.  Galectin-3: a novel biomarker for the prognosis of heart failure.

Authors:  Hilman Zulkifli Amin; Lukman Zulkifli Amin; Ika Prasetya Wijaya
Journal:  Clujul Med       Date:  2017-04-25

10.  N-terminal pro BNP and galectin-3 are prognostic biomarkers of acute heart failure in sub-Saharan Africa: lessons from the BAHEF trial.

Authors:  Mahmoud U Sani; Albertino Damasceno; Beth A Davison; Gad Cotter; Bongani M Mayosi; Christopher Edwards; Feriel Azibani; Tasneem Adam; Gulnaze Arif; Neusa Jessen; Karen Sliwa
Journal:  ESC Heart Fail       Date:  2020-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.